The effects of mefenamic acid and norethisterone on measured menstrual blood loss

Obstetrics and Gynecology

Volumn 76, Issue 1, 1990, Pages 85-88

  Cameron, Iain T ^a   Haining, Rosie ^a   Lumsden, Mary Anne ^a   Thomas, Vicki Reid ^a   Smith, Stephen K ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEFENAMIC ACID; NORETHISTERONE;

ARTICLE; BLEEDING; FEMALE; HUMAN; MENORRHAGIA; MENSTRUATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; FEMALE; HUMAN; MEFENAMIC ACID; MENORRHAGIA; MENSTRUATION; MIDDLE AGE; NORETHINDRONE; SUPPORT, NON-U.S. GOV'T;

EID: 0025356565     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Office of Population Censuses and Surveys. Hospital in patient statistics, 1985. London: Her Majesty’s Stationery Office, 1987: 848.
2. Bunker J, McPherson K, Henneman PL. Elective hysterectomy. In: Bunker JP, Barnes BA, Mosteller F, eds. Costs, risks and benefits of surgery. Oxford: Oxford University Press, 1977: 262–76.
3. Dicker RC, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982;144: 841–8.
4. Coulter A, McPherson K. The hysterectomy debate. Q J Soc Affairs 1986;2:379–96.
5. Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1970;110:713–9.
6. Bishop PMF, deAlmeida JCC. Treatment of functional menstrual disorders with norethisterone. Br Med J 1960;1:1103–5.
7. Anderson ABM, Haynes PJ, Guillebaud J, Turnbull AC. Reduction of menstrual blood loss by prostaglandin synthetase inhibitors. Lancet 1976;i:774–6.
8. Ylikorkala O, Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol 1983;90:78–83.
9. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss—a population study. Acta Obstet Gynecol Scand 1966; 45:320–51.
10. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964;16:244–8.
11. Fraser IS, Pearse C, Shearman RP, Elliott PM, McIlveen J, Markham R. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 1981;58:543–51.
12. Cameron IT. Prostaglandins, menstruation, and menstrual induction. (MD thesis). Edinburgh, Scotland: University of Edinburgh, 1988.
13. Moses LE. Comparison of crude and standardized anesthetic death rates. In: Bunker JP, Forrest WH Jr, Mosteller F, et al, eds. The National Halothane Study: Report of the subcommittee on the National Halothane Study. Washington, DC: Government Printing Office, 1969:259–66.
14. Wingo PA, Huezo CM, Rubin GL, Ory HW, Peterson HB. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985;152:803–8.
15. Gath D, Osborn M, Bungay G, et al. Psychiatric disorder and gynaecological symptoms in middle-aged women: A community survey. Br Med J 1987;294:213–8.
16. Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins 1987;34:99–110.
17. Fraser IS, McCarron G, Markham R, Robinson M, Smyth E. Long term treatment of menorrhagia with mefenamic acid. Obstet Gynecol 1983;61:109–12.